Skip to main content Skip to search Skip to main navigation
 Get a free Melatonin Spray with purchases over €100  Get a free Melatonin Spray with purchases over €100 X
Menu
Premium Nahrungsergänzungsmittel | artgerecht

CD13 - cell surface enzyme with significance in tumour biology, inflammation and drug development

CD13 is an enzyme on cell surfaces that plays a central role in cancer, inflammation and immune processes. Find out more about its function, tumour biology and therapeutic target structures.

Regular tips about health Regular tips about health
Lexicon Navigation

Things worth knowing about "CD13"

CD13 is an enzyme on cell surfaces that plays a central role in cancer, inflammation and immune processes. Find out more about its function, tumour biology and therapeutic target structures.

CD13, also known as Aminopeptidase N (APN), is a transmembrane enzyme that occurs on the surface of numerous cell types - in particular on myelocytes, endothelial cells, epithelial cells and tumour cells. It belongs to the family of zinc-dependent metalloproteases and plays an important role in the cleavage of peptides, cell migration, angiogenesis and immune regulation.

  • Protein degradation: cleaves terminal amino acids from oligopeptides

  • Regulation of inflammation: Involved in the activation and control of immune cells

  • Cell adhesion and migration: Supports the movement of immune cells in tissue

  • Angiogenesis: Promotes the formation of new blood vessels, especially during tissue remodelling processes

  • tumour tissues, especially in:

    • Soft tissue sarcomas

    • Colorectal carcinomas

    • Lung cancer

    • Liver cell carcinoma

    target molecule for tumour therapies. In the TRABTRAP study, for example, the tumour-specific peptide tTF-NGR is used, which binds to CD13 to selectively close the tumour vasculature and kill cancer cells through oxygen deprivation.

    tumour-associated vascular endothelial cells, but not on normal blood vessels, CD13 provides a platform for targeted drug delivery. Therapeutic substances or nanoparticles are provided with CD13-ligating molecules such as NGR peptides in order to selectively target tumour tissue.

    biomolecular marker to identify certain types of cancer or inflammatory conditions.

    receptor for certain coronaviruses (not SARS-CoV-2) and is involved in the pathogenesis of some virus-induced diseases.

    Literature references:

    • Trends in Molecular Medicine.

    • Journal of Clinical Investigation.

    • "CD13 as a molecular target in cancer therapy." Oncological research up to date.

    artgerecht

    Building Blocks for a Healthy Life

    As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
    The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.